RESUMO
La presente publicación resume los logros y metas de la gestión institucional, que son el resultado de acciones que han sido iniciadas durante los 365 años de vida institucional con una reconocida trayectoria en el cuidado de la salud de la mujer, el recién nacido, el niño y el adolescente, por lo que se debe reconocer las importantes decisiones tomadas en su momento, la visión de futuro que tuvieron gestiones anteriores, y el trabajo altamente calificado que hacen sus trabajadores al servicio de la salud.
Assuntos
Aniversários e Eventos Especiais , Gestão em Saúde , Hospitais , PeruRESUMO
La presente publicación resume los logros y metas de la gestión institucional, que son el resultado de acciones que han sido iniciadas durante los 365 años de vida institucional con una reconocida trayectoria en el cuidado de la salud de la mujer, el recién nacido, el niño y el adolescente, por lo que se debe reconocer las importantes decisiones tomadas en su momento, la visión de futuro que tuvieron gestiones anteriores, y el trabajo altamente calificado que hacen sus trabajadores al servicio de la salud(AU)
Assuntos
Hospitais , Gestão em Saúde , Aniversários e Eventos Especiais , PeruRESUMO
A number of factors influence how medicines are used in each community, but drug registration is the initial and usually necessary step. In the course of an external advisory consultation, the list of approved medicines in Peru in 1998 was examined. Of 1672 newly approved forms, 119 were of 49 new chemical entities. Sildenafil, meloxicam, nimesulide, candesartan, irebesartan, naratriptan, trovafloxacin and grepafloxacin were among them. Several aspects about the new global drug situation and 'real' health needs versus 'induced' health needs are discussed from this example.
Assuntos
Países em Desenvolvimento/estatística & dados numéricos , Aprovação de Drogas/estatística & dados numéricos , Necessidades e Demandas de Serviços de Saúde/estatística & dados numéricos , Aprovação de Drogas/métodos , Revisão de Uso de Medicamentos , Humanos , Avaliação das Necessidades , Peru , Farmacoepidemiologia/estatística & dados numéricos , Medição de RiscoRESUMO
A study of 4 groups of serum samples from Cuba, Costa Rica, Nicaragua and Panama was made to determine the serotypes of dengue virus causing epidemics or outbreaks by using IgM antibody-capture ELISA(MAC-ELISA). Dengue-IgM diagnostic kit was independently used in each of the serotypes and an index value was calculated (optical density of the sample/cut-off value) in each case, with which two statistical analyses were made: Fisher's variances and Litter significant difference (LSD) calculation. Such calculations allowed determining that in Cuba and Panama, serotype 2 circulated whereas in Costa Rica, serotype 1 prevailed. These were the isolated serotypes in various epidemics. Regarding Nicaragua, very heterogeneous responses were obtained, the responsible serotype could not be determined since more than two serotypes co-circulated in this country.